论文部分内容阅读
16例初发急性心肌梗塞患者用尿激酶进行静脉溶栓治疗,8例出现再灌注性心律失常,且多为室性早搏、加速性室性自主心律和室性心动过速。16例急性心肌梗塞患者溶栓治疗后,8例出现冠状动脉再通。冠状动脉再通组再灌注性心律失常发生率为87％,ST段下降发生率为75％,明显高于冠状动脉非再通组。结论:加速性室性自主心律和室性心动过速是溶栓治疗后冠状动脉再通最好的无创指标;溶栓治疗后ST段迅速下降伴随着再灌注性心律失常发生率的增加。
16 patients with newly diagnosed acute myocardial infarction were treated with intravenous thrombolytic therapy with urokinase, and 8 patients had reperfusion arrhythmia, and most of them were premature ventricular contractions, accelerated ventricular tachycardia and ventricular tachycardia. Thrombolysis in 16 patients with acute myocardial infarction, recurrent coronary artery in 8 cases. Coronary artery reperfusion group, the incidence of reperfusion arrhythmia was 87%, ST segment decline was 75%, significantly higher than non-coronary reperfusion group. Conclusions: Acceleration of ventricular tachycardia and ventricular tachycardia is the best non-invasive index for recanalization of coronary artery after thrombolysis. The rapid decline of ST segment after thrombolytic therapy is associated with the increase of reperfusion arrhythmia.